Cargando…

Radiomic Phenotypes for Improving Early Prediction of Survival in Stage III Non-Small Cell Lung Cancer Adenocarcinoma after Chemoradiation

SIMPLE SUMMARY: Personalized therapy of non-small cell lung cancer (NSCLC) relies heavily on histopathological analyses that require invasive biopsies that have relatively high costs, provide limited assessment of tumor heterogeneity and are associated with potentially life-threatening complications...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luna, José Marcio, Barsky, Andrew R., Shinohara, Russell T., Roshkovan, Leonid, Hershman, Michelle, Dreyfuss, Alexandra D., Horng, Hannah, Lou, Carolyn, Noël, Peter B., Cengel, Keith A., Katz, Sharyn, Diffenderfer, Eric S., Kontos, Despina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833400/ https://www.ncbi.nlm.nih.gov/pubmed/35158971 http://dx.doi.org/10.3390/cancers14030700

Ejemplares similares

Are radiomic signatures ready for incorporation in the clinical pipeline?
por: Singh, Apurva, et al.
Publicado: (2023)

Resampling and harmonization for mitigation of heterogeneity in image parameters of baseline scans
por: Singh, Apurva, et al.
Publicado: (2022)

Development of a robust radiomic biomarker of progression-free survival in advanced non-small cell lung cancer patients treated with first-line immunotherapy
por: Singh, Apurva, et al.
Publicado: (2022)

Impact of Interobserver Variability in Manual Segmentation of Non-Small Cell Lung Cancer (NSCLC) Applying Low-Rank Radiomic Representation on Computed Tomography
por: Hershman, Michelle, et al.
Publicado: (2021)

Machine learning highlights the deficiency of conventional dosimetric constraints for prevention of high-grade radiation esophagitis in non-small cell lung cancer treated with chemoradiation
por: Luna, José Marcio, et al.
Publicado: (2020)

Improved generalized ComBat methods for harmonization of radiomic features
por: Horng, Hannah, et al.
Publicado: (2022)

Generalized ComBat harmonization methods for radiomic features with multi-modal distributions and multiple batch effects
por: Horng, Hannah, et al.
Publicado: (2022)

Interactive Machine Learning-Based Multi-Label Segmentation of Solid Tumors and Organs
por: Bounias, Dimitrios, et al.
Publicado: (2021)

Multimodality imaging of Surgicel(®), an important mimic of post-operative complication in the thorax
por: Roshkovan, Leonid, et al.
Publicado: (2021)

Radiomic phenotyping of the lung parenchyma in a lung cancer screening cohort
por: Haghighi, Babak, et al.
Publicado: (2023)

First-ever Abscopal Effect after Palliative Radiotherapy and Immuno-gene Therapy for Malignant Pleural Mesothelioma
por: Barsky, Andrew R, et al.
Publicado: (2019)

A single-center retrospective cohort study of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma
por: Wang, Xiao, et al.
Publicado: (2022)

A 53-Year-Old Man Presents to the ED With Shortness of Breath, Cough, and Fever
por: Roshkovan, Leonid, et al.
Publicado: (2021)

Combining radiomic phenotypes of non-small cell lung cancer with liquid biopsy data may improve prediction of response to EGFR inhibitors
por: Yousefi, Bardia, et al.
Publicado: (2021)

Three-dimensional printing of patient-specific computed tomography lung phantoms: a reader study
por: Shapira, Nadav, et al.
Publicado: (2023)

Cardiovascular Substructure Dose and Cardiac Events following Proton- and Photon-Based Chemoradiotherapy for Non-Small Cell Lung Cancer
por: Natarajan, Jyotsna, et al.
Publicado: (2023)

Radiomics in Oncology III
por: Zerunian, Marta, et al.
Publicado: (2023)

FLT PET Radiomics for Response Prediction to Chemoradiation Therapy in Head and Neck Squamous Cell Cancer
por: Ulrich, Ethan J., et al.
Publicado: (2019)

Predicting outcomes for locally advanced rectal cancer treated with neoadjuvant chemoradiation with CT-based radiomics
por: Wang, Fuqiang, et al.
Publicado: (2022)

MRI Radiomics for Prediction of Tumor Response and Downstaging in Rectal Cancer Patients after Preoperative Chemoradiation
por: Chen, Haihui, et al.
Publicado: (2020)

Alveolar adenoma of the lung: multidisciplinary case discussion and review of the literature
por: Roshkovan, Leonid, et al.
Publicado: (2020)

FET PET Radiomics for Differentiating Pseudoprogression from Early Tumor Progression in Glioma Patients Post-Chemoradiation
por: Lohmann, Philipp, et al.
Publicado: (2020)

Dietary Flaxseed in Non-Small Cell Lung Cancer Patients Receiving Chemoradiation
por: Berman, Abigail T, et al.
Publicado: (2013)

Relative biological effectiveness of simulated solar particle event proton radiation to induce acute hematological change in the porcine model
por: Sanzari, Jenine K., et al.
Publicado: (2014)

Monte Carlo modeling in CT-based geometries: dosimetry for biological modeling experiments with particle beam radiation
por: Diffenderfer, Eric S., et al.
Publicado: (2014)

Real-World Analysis of Durvalumab after Chemoradiation in Stage III Non-Small-Cell Lung Cancer
por: Preti, Beatrice T. B., et al.
Publicado: (2023)

Deep Learning and Radiomics predict complete response after neo-adjuvant chemoradiation for locally advanced rectal cancer
por: Bibault, Jean-Emmanuel, et al.
Publicado: (2018)

Radiomics Analysis of (18)F-FDG PET/CT for Prognosis Prediction in Patients with Stage III Non-Small Cell Lung Cancer Undergoing Neoadjuvant Chemoradiation Therapy Followed by Surgery
por: Yoo, Jang, et al.
Publicado: (2023)

Radiomics for the Prediction of Pathological Complete Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Prospective Observational Trial
por: Shi, Liming, et al.
Publicado: (2023)

Chemoradiation with capecitabine and mitomycin-C for stage I-III anal squamous cell carcinoma
por: Thind, Govin, et al.
Publicado: (2014)

Practical challenges in patients with stage III NSCLC receiving checkpoint inhibitors after chemoradiation
por: Shukla, Nikhil A, et al.
Publicado: (2020)

Duodenocaval Fistula: A Spontaneous Complication of Chemoradiation Therapy in Stage III Ovarian Cancer
por: Assaad, Marc, et al.
Publicado: (2022)

Author Correction: Deep Learning and Radiomics predict complete response after neo-adjuvant chemoradiation for locally advanced rectal cancer
por: Bibault, Jean-Emmanuel, et al.
Publicado: (2018)

Assessment of treatment response during chemoradiation therapy for pancreatic cancer based on quantitative radiomic analysis of daily CTs: An exploratory study
por: Chen, Xiaojian, et al.
Publicado: (2017)

A FDG-PET radiomics signature detects esophageal squamous cell carcinoma patients who do not benefit from chemoradiation
por: Li, Yimin, et al.
Publicado: (2020)

Pre-Treatment Computed Tomography Radiomics for Predicting the Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Retrospective Study
por: Mao, Yitao, et al.
Publicado: (2022)

Chemoradiation followed by adjuvant durvalumab in stage III non–small cell lung cancer: Real‐world comparison of treatment outcomes to historical controls treated with chemoradiation alone
por: Saad, Akram, et al.
Publicado: (2022)

Genomic Analyses for Predictors of Response to Chemoradiation in Stage III Non-Small Cell Lung Cancer
por: Luo, Leo Y., et al.
Publicado: (2020)

Concurrent Chemoradiation With or Without Durvalumab in Elderly Patients With Unresectable Stage III NSCLC: Safety and Efficacy
por: Lau, Sally C.M., et al.
Publicado: (2021)

Assessment of Intratumoral and Peritumoral Computed Tomography Radiomics for Predicting Pathological Complete Response to Neoadjuvant Chemoradiation in Patients With Esophageal Squamous Cell Carcinoma
por: Hu, Yihuai, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t9ti8lflb883sdf1arbea4fp7h